ROMAGNOLI, Renato
 Distribuzione geografica
Continente #
NA - Nord America 11725
EU - Europa 7675
AS - Asia 4297
SA - Sud America 218
AF - Africa 114
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 17
Totale 24133
Nazione #
US - Stati Uniti d'America 11519
CN - Cina 2815
IT - Italia 1860
IE - Irlanda 1069
FR - Francia 802
SE - Svezia 724
DE - Germania 564
UA - Ucraina 476
FI - Finlandia 453
KR - Corea 425
AT - Austria 323
GB - Regno Unito 296
JP - Giappone 240
PL - Polonia 222
VN - Vietnam 209
BE - Belgio 173
CA - Canada 159
IN - India 156
DK - Danimarca 143
ES - Italia 136
TR - Turchia 110
NL - Olanda 108
BR - Brasile 86
AU - Australia 80
TW - Taiwan 72
AR - Argentina 62
RU - Federazione Russa 59
HK - Hong Kong 42
CH - Svizzera 40
RO - Romania 40
CO - Colombia 38
MX - Messico 38
UZ - Uzbekistan 38
GR - Grecia 37
PT - Portogallo 35
EG - Egitto 32
PH - Filippine 28
TH - Thailandia 25
HU - Ungheria 24
ID - Indonesia 22
KE - Kenya 22
IR - Iran 21
CZ - Repubblica Ceca 18
IL - Israele 18
NO - Norvegia 18
PE - Perù 17
EU - Europa 16
HR - Croazia 15
SA - Arabia Saudita 15
SG - Singapore 15
CL - Cile 12
SN - Senegal 10
MY - Malesia 9
BG - Bulgaria 8
ZM - Zambia 8
NZ - Nuova Zelanda 7
PK - Pakistan 7
ZA - Sudafrica 7
RS - Serbia 6
SD - Sudan 6
BA - Bosnia-Erzegovina 5
CM - Camerun 5
JO - Giordania 5
IQ - Iraq 4
MN - Mongolia 4
NI - Nicaragua 4
SI - Slovenia 4
TN - Tunisia 4
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
MM - Myanmar 3
MV - Maldive 3
MZ - Mozambico 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
GM - Gambi 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
NP - Nepal 2
UG - Uganda 2
VE - Venezuela 2
A1 - ???statistics.table.value.countryCode.A1??? 1
BD - Bangladesh 1
CU - Cuba 1
GT - Guatemala 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
MU - Mauritius 1
NA - Namibia 1
PS - Palestinian Territory 1
Totale 24132
Città #
Chandler 1852
Beijing 1453
Dublin 1066
Ann Arbor 899
Fairfield 766
Houston 674
Villeurbanne 512
Torino 471
Princeton 448
Wilmington 428
Woodbridge 428
Dearborn 407
Medford 400
Jacksonville 372
Nyköping 351
Vienna 304
Ashburn 284
Redwood City 274
Cambridge 272
Seattle 261
Warsaw 199
Pisa 178
Guangzhou 148
Shanghai 127
Fremont 121
Hangzhou 120
Dong Ket 113
Milan 110
Boston 102
Brussels 101
Turin 99
Nanjing 91
Boardman 69
Chengdu 66
Rome 61
Ottawa 56
Wuhan 53
Hefei 50
San Diego 47
Hebei 46
Tokyo 46
Taipei 45
San Mateo 44
Seoul 43
Norwalk 42
Kunming 39
Falls Church 38
London 37
Chongqing 36
Zhengzhou 36
Toronto 34
Paris 31
Berlin 28
Düsseldorf 28
Fuzhou 28
Barcelona 27
Changchun 26
Silver Spring 26
Mountain View 24
Upper Marlboro 24
Changsha 23
Jinan 23
Istanbul 22
Rochester 22
Duncan 21
Rotterdam 20
Verona 20
Padova 19
Central District 18
Chicago 18
Guiyang 18
Nanchang 18
São Paulo 18
Tianjin 18
Buffalo 17
Philadelphia 17
Bologna 16
Buenos Aires 16
Jakarta 16
Madrid 16
New York 16
Xian 16
Hanover 15
Lima 15
Malatya 15
Melbourne 15
Phoenix 15
Strasbourg 15
Chennai 14
Heidelberg 14
New Delhi 14
Shenyang 14
Ankara 13
San Francisco 13
Delhi 12
Des Moines 12
Gent 12
Groningen 12
Piemonte 12
Redmond 12
Totale 15213
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 791
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 742
Liver graft preconditioning, preservation and reconditioning 475
Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. 458
Human liver stem cells improve liver injury in a model of fulminant liver failure. 438
Liver transplantation for aHUS: still needed in the eculizumab era? 391
Surgical management of post-cholecystectomy bile duct injuries: referral patterns and factors influencing early and long-term outcome 358
Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials 355
Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study 341
Simultaneous Liver-Kidney Transplantation in Adults: A Single-center Experience Comparing Results with Isolated Liver Transplantation 311
Liver transplantation in severe methylmalonic acidemia: the sooner, the better 308
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 292
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 258
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 237
Surgical resection for hepatocellular carcinoma: moving from what can be done to what is worth doing 226
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication 217
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 209
International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK 208
Liver transplantation after severe hepatic trauma: a sustainable practice. A single-center experience and review of the literature 208
Liver transplantation for symptomatic centrohepatic biliary cystadenoma 175
Recellularization of rat liver scaffolds by human liver stem cells 173
Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets 172
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 171
Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child with CD40 Ligand Deficiency and Cryptosporidium -Induced Liver Cirrhosis 160
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation 154
Human Liver Stem Cell-Derived Microvesicles Inhibit Hepatoma Growth in SCID Mice By Delivering Anti-tumor microRNAs. 152
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 151
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY 147
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 145
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 144
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 141
Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction 140
Left-sided portal hypertension: successful management by laparoscopic splenectomy following splenic artery embolization. 139
Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation 138
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 137
PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia 135
The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor 134
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 131
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 128
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period 126
Normothermic Machine Perfusion of Donor Livers Without the Need for Human Blood Products 125
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration 124
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model" 124
Liver transplantation for “mass-forming” sclerosing cholangitis after laparoscopic cholecystectomy 123
Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency 120
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 114
Graft factors as determinants of postoperative delirium after liver transplantation 111
Ansa digiunale ad Y secondo Roux e reflusso biliare 110
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 107
Liver transplantation with cavo-portal hemi-transposition: report of a case with venous pressure measurements 106
Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors 104
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 103
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 103
Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases 101
Bilimetria esofago-gastrica delle 24 ore con BILITEC 2000 98
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 98
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 97
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 96
Centenarian Livers: Very Long-Term outcomes of very old grafts 96
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 94
Porcine Isolated Liver Perfusion for the Study of Ischemia Reperfusion Injury: A Systematic Review. 94
Carbapenemase Producing Klebsiella Pneumoniae Infection in Liver Transplant Recipients: Review of Our Experience 93
Transplantation of the liver from a HBcAb positive donor into a HCV-RNA positive recipient adversely affects graft survival and worsens the course of HCV recurrence 92
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study 91
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 91
The effect of D-MELD on graft survival and course of HCV recurrence in HCV-RNA positive recipients after liver transplantation 90
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 90
“U-shaped” mesoportal jump graft to manage portal vein thrombosis during liver transplantation: A case report 88
Radiotherapy treatment strategies for squamous cell carcinoma of the cervical oesophagus: Moving toward better outcomes 87
www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH 85
Serological characterization of occult HBV infection in liver donors 85
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA 85
The Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. 84
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection 82
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 82
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 82
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 81
NBAS mutations cause acute liver failure: When acetaminophen is not a culprit 81
LIVER TRANSPLANTATION IN PATIENTS WITH PREVIOUS NON-HODGKIN LYMPHOMA: REPORT OF A SINGLE CENTRE EXPERIENCE 80
Risk factors for arterial hypertension after liver transplantation 80
24-hour pH and bile monitoring of the denervated whole stomach as an esophageal substitute. 79
DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IN THE ASSESSMENT OF SIGNIFICANT LIVER FIBROSIS IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS 79
Thromboelastogram changes in the perioperative period of adult living liver donation 78
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 77
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 77
LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION 76
Peritoneal leukocytoclastic vasculitis as a cause of unexplained persistent ascites after liver transplantation 76
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 76
Behind D-MELD: The Role of Primary Indication (HCV or HBV) as Significant Covariate in the Outcome Prediction after Liver Transplants 76
Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient 75
MULTIMODAL TREATMENT OF HCC IN CIRRHOTIC LIVER, THE ROLE OF SURGERY. THE EXPERIENCE OF THE LIVER TRANSPLANT CENTRE OF TURIN 75
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 74
Early liver transplantation for neonatal-onset methylmalonic acidemia 73
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation 73
Therapeutical Implications in the Study of Mutation of the CYP3A5*3 in the Matabolism of Tacrolimus in Paediatric Livel Transplantation: the Experience of a Single Medical Centre 72
Liver transplantation with a partial graft is a risk factor for de novo tumors after transplant in the adult population 72
Protective Effects of Human Liver Stem Cell-Derived Extracellular Vesicles in a Mouse Model of Hepatic Ischemia-Reperfusion Injury 72
An unusual inflammatory hepatic lesion 71
Assessment and treatment of symptomatic duodenal reflux 71
Metabolic Syndrome after liver transplantation: have risk factors changed over time? 71
Totale 15286
Categoria #
all - tutte 46286
article - articoli 0
book - libri 0
conference - conferenze 14733
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018104 0000 00 00 000104
2018/20192407 9915222399 174143 131264 102291474255
2019/20203818 171131156412 277679 455273 374355274261
2020/20213230 319218199165 252197 319281 281292264443
2021/20224382 208197237301 366311 287283 182354784872
2022/20235777 705474179522 4351386 496444 5881823660
Totale 25418